"The Cholesterol Conspiracy" Revised 2nd Edition

How Pharmaceutical Companies Continue to Hide the Truth About Cholesterol.

Includes the Newest Research Findings Showing the Effectiveness of Nutritional Supplements for the Prevention of Heart Disease and Stroke.

This audiobook is read by the author, Ladd R. McNamara, M.D.

Copies of the Cholestrol Conspiracy are available!

Audio Book and Paper Back versions are available at http://www.laddmcnamara.com/bookstore along with other books written by Dr. McNamara.

Ladd McNamara, M.D. (Photo)

Episode 14: The “Best” Way to Reduce the Risk of Cardiac Death: Part 1 (According to Dr. Ladd McNamara)

In this episode Dr. Ladd McNamara discusses vitamins, minerals, antioxidants, and essential fatty acids: a real an alternative way to reduce the risk of death from heart disease and stroke.

  • Chapter 33: Vitamins, Minerals, Antioxidants, and Essential Fatty Acids: The Real Way to Reduce the Risk of Death from Heart Disease and Stroke – Part 1

Chapter Excerpts

The answer to lowering the risk of arteriosclerosis, heart disease and stroke is to reduce the oxidative damage to the LDL cholesterol, triglycerides, and the arterial lining so that plaque does not form.

The Cholesterol Conspiracy is about the makers of statin drugs hiding the truth that antioxidants work better than the statin drugs to reduce the risk of cardiac death. Antioxidants appear to be much more effective in reducing the risk of death from heart disease than current treatments using aspirin or cholesterol-lowering drugs combined.

There is a balance of D-alpha tocopherol and gamma tocopherol that is required to protect the fat and the protein components, respectively, or LDL cholesterol from oxidation. LDL that is not oxidized does not stick to the arterial walls.

Ladd McNamara, M.D.

Chapter References

  • 85: Aviram M. HDL–associated paraoxonase 1 (PON1) and dietaryantioxidants attenuate lipoprotein oxidation, macrophage foam cells formation and atherosclerosis development. Pathophysiol Haemost Thromb. 2006;35(1-2):146-51.
  • 86: Hertog M, Feskens E, Hollman P, Katan M, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly study. Lancet 1993 Oct 23;342(8878):1007-1011.
  • 87: Street D, et al. A population based case control study of the association of serum antioxidants and myocardial infarction. Am J Epidemiol. 1991 134:719-720.
  • 88: Steinberg D, et al. Antioxidants in the prevention of human atherosclerosis. Circulation. 1992 85:6:2338-2343.
  • 89: Gey K, et al. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutri. 1991 53:326S-334S.
  • 90: Stampfer M, et al. Vitamin E consumption and the risk of coronary disease in women. New Engl J Med. 1993 328:1444-1449.
  • 91: Rimm E, Stampfer M, et al. Vitamin E consumption and the risk of coronary artery disease in men. New Engl J Med. 1993 328:1450-1456.
  • 92: Munteanu, A. et al. Anti-atherosclerotic effects of vitamin E – Myth or reality? J Cell Mol Med., 2004, Jan-Mar;8(1):59-76.
  • 93: I-Min Lee, et al. Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer. JAMA. 2005, Vol. 294, 56-65.
  • 94: Losonczy K, et al. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the established populations for epidemiologic studies of the elderly. Am J Clin Nutri. 1996 64:190-196.

Ladd McNamara, M.D.

Post a Comment

Your email is never shared. Required fields are marked *

*
*